XML 22 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Shareholders' Deficit - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
[2]
Common Stock
Additional Paid-in- Capital
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
[2]
Beginning balance (in shares) at Dec. 31, 2017     56,679,968          
Beginning balance at Dec. 31, 2017 $ (258,601)   $ 951 $ 182,448 $ (4,699) $ (1,064,573) $ 627,272  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 216,355           216,355  
Other comprehensive income (loss) (747)       (747)      
Share based payment activity (in shares)     918,397          
Share based payment activity 56,349     30,722   25,627    
Dividends declared ($0.215 per share) (48,449)           (48,449)  
Treasury purchases (in shares)     (1,919,158)          
Treasury purchases (148,679)         (148,679)    
Ending balance (in shares) at Dec. 31, 2018     55,679,207          
Ending balance at Dec. 31, 2018 $ (183,772)   $ 951 213,170 (5,446) (1,187,625) 795,178  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member              
Net income $ 222,878           222,878  
Other comprehensive income (loss) 896       896      
Share based payment activity (in shares)     654,694          
Share based payment activity 38,056     19,698   18,358    
Dividends declared ($0.215 per share) (48,609)           (48,609)  
Treasury purchases (in shares)     (631,273)          
Treasury purchases (50,638)         (50,638)    
Other [1] $ (2,322)     (1,708)     (614)  
Ending balance (in shares) at Dec. 31, 2019 55,702,628   55,702,628          
Ending balance at Dec. 31, 2019 $ (23,511) $ (6,831) $ 951 231,160 (4,550) (1,219,905) 968,833 $ (6,831)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 75,387           75,387  
Other comprehensive income (loss) (96)       (96)      
Share based payment activity (in shares) [3]     506,953          
Share based payment activity [3] 17,201     2,761   14,877 (437)  
Dividends declared ($0.215 per share) [3] (12,452)           (12,452)  
Treasury purchases (in shares)     (674,027)          
Treasury purchases $ (55,450)         (55,450)    
Ending balance (in shares) at Dec. 31, 2020 55,535,554   55,535,554          
Ending balance at Dec. 31, 2020 $ (5,752)   $ 951 $ 233,921 $ (4,646) $ (1,260,478) $ 1,024,500  
[1] (1) Impacts of i) adoption of Topic 606 related to a foreign joint venture accounted for as an equity method investment on Retained Earnings and ii) transaction resulting in an increase in ownership of a consolidated joint venture on Additional Paid-in-Capital.
[2] (2) Reflects the cumulative effect of Topic 326, which was adopted on January 1, 2020. Refer to Note 1 for additional details.
[3] (3) During the fourth quarter of 2019, the Company's board of directors announced a 5% increase to the quarterly dividend rate to $0.225 per share from $0.215 per share, beginning with the dividend payable in the first quarter of 2020. On February 28, 2020, the Company’s board of directors declared a quarterly cash dividend of $0.225 per share of common stock. The dividend was payable on April 16, 2020 to shareholders of record on April 2, 2020. Subsequent to the payment of the dividend, in light of uncertainty resulting from the COVID-19 pandemic, we suspended future, undeclared dividends while the pandemic is significantly impacting travel. During 2020, accumulated dividends were paid to certain shareholders upon vesting of certain performance-based stock grants which are captured in Share based payment activity.